| Preface | 6 |
---|
| Abstract | 8 |
---|
| Acknowledgements | 10 |
---|
| Contents | 12 |
---|
| Abbreviations | 14 |
---|
| Chapter 1: Background | 18 |
---|
| 1.1 Innate Immunity, Toll-Like Receptors and Danger Signals | 18 |
| 1.2 The Ovary, Tissue Remodeling and Immune Privilege | 21 |
| 1.3 Design | 23 |
| Chapter 2: Materials and Methods | 24 |
---|
| 2.1 Cyclic and Superovulated Ovaries from Rats, Hamsters, and Rabbits as well as Canine, Bovine and Human Ovaries | 24 |
| 2.1.1 Fibrinolytic Activity and Implants on the Chicken Chorioallantoic Membrane | 26 |
| 2.1.2 Fixation, Staining and Counting Ovarian Structures | 28 |
| 2.2 Cell Culture Subtypes from Follicles Derived from Patients Under IVF Therapy | 28 |
| 2.3 Cell Culture Subtypes from Bovine CL and Characterization | 31 |
| Chapter 3: Footmarks of INIM | 33 |
---|
| 3.1 The Complement System as Danger Sensor in General and in the Ovary | 33 |
| 3.2 Mild Danger with Mild Response | 35 |
| 3.2.1 Implantation of the Ovary into the CAM | 35 |
| 3.2.2 Follicular Atresia | 35 |
| 3.3 Moderate Danger by Preovulatory Follicle Rupture and Acute Inflammation with Eosinophils | 37 |
| 3.3.1 Recruitment of Eosinophils and SP-Like Expression | 42 |
| 3.4 Severe Danger in Superovulated Ovaries with Intra-ovarian Oocyte Release (IOR) and Thrombus Formation | 46 |
| Chapter 4: Cytokeratin-Positive Cells (CK+) as Potential Dendritic Cells | 51 |
---|
| 4.1 Dendritic Cells, the TLR System in General and in the Ovary | 51 |
| 4.2 Localization of CK+ Cells in the Intact Ovary | 54 |
| 4.2.1 Follicles in Fetal and Adult Ovaries | 55 |
| 4.2.2 Corpus Luteum | 58 |
| Chapter 5: Characterization of Isolated CK+ Cells | 61 |
---|
| 5.1 CK+ Cells from Preovulatory Follicles with TLR4 Expression | 61 |
| 5.2 CK+ Cells from CL in Comparison with CK- Cells | 69 |
| 5.2.1 Effects of IFN-gamma on CK+ Cells from the CL Compared to CK- Cells and to Surface Epithelial Cells | 78 |
| 5.2.2 Reflections on Quality of the CK+ Type 1 and Similarity with the Type 5 | 82 |
| Chapter 6: Working Hypothesis and Challenges | 93 |
---|
| Chapter 7: Clinical Perspectives | 99 |
---|
| Chapter 8: Concluding Summary and Remarks | 102 |
---|
| References | 104 |
---|
| Index | 115 |